Dupont Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Dupont Capital Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-17,519	Closed	-$341K	–	1078
2018 Q1	$341K	Hold	17,519	–	–	0.01%	743
2017 Q4	$292K	Sell	17,519 -46,181	-72%	-$846K	0.01%	759
2017 Q3	$1.29M	Buy	63,700 +1,821	+3%	+$34.8K	0.03%	472
2017 Q2	$996K	Sell	61,879 -56,184	-48%	-$830K	0.02%	527
2017 Q1	$1.49M	Buy	118,063 +99,222	+527%	+$1.2M	0.03%	418
2016 Q4	$250K	Hold	18,841	–	–	0.01%	779
2016 Q3	$447K	Buy	+18,841	New	+$506K	0.01%	581
2015 Q2	–	Sell	-27,400	Closed	-$1.28M	–	650
2015 Q1	$1.28M	Sell	27,400 -53,190	-66%	-$2.12M	0.03%	421
2014 Q4	$2.55M	Buy	+80,590	New	+$2.36M	0.05%	297

Dupont Capital Management's IPXL Position: Q2 2018 in Review

Dupont Capital Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 17,519 shares — an estimated $341K sold.

Dupont Capital Management first reported a position in IPXL in Q4 2014 and held it in 9 quarters. The position peaked at $2.55M in Q4 2014. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Dupont Capital Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Dupont Capital Management sold 17,519 Impax Laboratories, Inc. shares in Q2 2018, an estimated $341K.
Dupont Capital Management first reported a position in Impax Laboratories, Inc. in Q4 2014 and held it in 9 quarters.
Dupont Capital Management's Impax Laboratories, Inc. position peaked at $2.55M in Q4 2014.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Dupont Capital Management's 13F filing for Q2 2018, filed 30 Jul 2018.